Background-The risk of atrial fibrillation (AF) after coronary bypass surgery has been related to redox state, inflammation, and ischemia. Platelet activation is common to all of these pathways. We investigated the relation between AF and preoperative soluble CD40 ligand (sCD40L), a proinflammatory marker released by activated platelets. Furthermore, we studied the role of inflammation, endothelial function, and redox state in this relation. Methods and Results-sCD40L levels were measured in 144 patients in sinus rhythm the day before off-pump coronary artery surgery. Systemic inflammation was assessed from levels of C-reactive protein and soluble intercellular adhesion molecule-1, and endothelial function was assessed from the brachial artery flow-mediated dilatation response. Graft samples were collected during surgery to assess vascular redox state. AF occurred in 33% of patients after surgery, with 3% still in AF after 6 weeks. Preoperative sCD40L levels were significantly higher in those who developed in-hospital AF (odds ratio for a 1-SD increase in log[sCD40L]ϭ1.97; 95% CI, 1.21 to 3.22; Pϭ0.007; after adjustment for age, sex, Euroscore, and total duration of operation). sCD40L and vascular superoxide levels were higher in patients still in AF at 6 weeks, and endothelial function was lower, although the small number of events precluded statistical analysis in this group. Systemic endothelial function, redox state, and preoperative markers of systemic inflammation were not associated with in-hospital postoperative AF. Conclusions-Preoperative platelet activation, as assessed by sCD40L levels, is a novel predictor of postoperative AF, independent of systemic endothelial function, vascular redox state, and systemic inflammation. (Circulation. 2009; 120[suppl 1]:S170-S176.)
A trial fibrillation (AF) is common after coronary artery bypass graft surgery (CABG). 1, 2 Myocardial ischemia due to dysfunctional grafts has been implicated in postoperative arrhythmogenesis, 2 as has the systemic inflammatory response to surgery. 3 Endothelial and myocardial oxidases, stimulated by proinflammatory mediators, may then promote new onset of AF through altered atrial electric properties. 4 Platelet activation links these biologic mechanisms. Soluble CD40 ligand (sCD40L), released by activated platelets, is involved in proinflammatory transcriptional pathway regulation, including myocardial oxidative stress. 5, 6 Recently, elevated values of sCD40L have been found in patients with AF and have been proposed as 1 explanation for increased thrombosis during the arrhythmia. 7 However, prothrombotic tendencies may also be relevant to the onset of AF, particularly after CABG. 8 We tested the hypothesis that preoperative sCD40L levels would be related to the risk of postoperative AF in patients in sinus rhythm undergoing off-pump CABG. Furthermore, we hypothesized that preoperative endothelial function, vascular redox state, and systemic inflammation partly mediate the association between preoperative sCD40L levels and postoperative AF. or those receiving amiodarone or digoxin were excluded. Antiplatelet medication (aspirin and clopidogrel) was discontinued 1 week before surgery. Detailed information was collected on medical history (including current medication, cardiac risk factors and comorbidities, Euroscore and Parsonnet scores, left ventricular function, and left atrial diameter) the day before operation. Venous blood samples were also obtained preoperatively, and systemic arterial endothelial function was evaluated by brachial artery flowmediated dilatation (FMD), as previously described. 9 The next day, surgery was performed off-pump with a heparin protocol to maintain an activated coagulation time at Ͼ400 seconds. Paired samples of left internal mammary artery (LIMA) and saphenous vein (SV) grafts were collected before heparin administration to determine vascular superoxide generation. 10 Clinical data were then collected prospectively on all patients during their hospital stay and again at a 6-week, routine, postsurgical follow-up clinic. The study was approved by the research ethics committee, and all patients gave written, informed consent. The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Assessment of Preoperative sCD40L and Inflammatory Markers
Venous blood samples were centrifuged at 2500 rpm at 4°C for 10 minutes, whereas serum and plasma were collected and stored at Ϫ80°C until assayed. Serum sCD40L was determined by ELISA (ELISA kit by Bender Medsystems; intra-assay variability 4.0%, interassay variability 6.8%, and lowest detection limit 0.062 ng/mL). High-sensitivity C-reactive protein (CRP) was measured by particleenhanced immunonephelometry (N Latex, Dade-Behring Marburg GmbH, Marburg, Germany; intra-assay variability 3.4%, interassay variability 3.8%, and lowest detection limit 0.175 mg/L.). Serum levels of soluble intercellular adhesion molecule (sICAM-1) were determined by ELISA (R&D Systems, Germany; intra-assay variability 3.6%, interassay variability 4.4%, and lowest detection limit 0.096 ng/mL).
Assessment of Preoperative Endothelial Function
FMD and endothelium-independent vasodilatation of the brachial artery were measured, as previously described, 9, 11 with a linear-array transducer, Philips Sonos 5500, and automated off-line analysis (Vascular Analyser, Medical Imaging Applications LLC). In brief, brachial artery diameter was recorded before and 60 seconds after a 5-minute forearm blood flow occlusion. Another measurement was made 3 minutes after a sublingual spray of glyceryl trinitrate was given (Ϸ200 g). FMD and endothelium-independent dilatation of the brachial artery were recorded as the change in vessel diameter after forearm ischemia and sublingual glyceryl trinitrate, respectively. 12, 13 Mean intraobserver and interobserver variability of FMD measurements in our laboratory in 20 healthy volunteers was 3.2% and 4.2%, respectively.
Assessment of Vascular Superoxide Production
Samples of SV and LIMA were transferred to the laboratory within 30 minutes from harvesting, as we have previously described. 10 Vascular superoxide production was measured from paired segments of intact SV and LIMA with lucigenin-enhanced chemiluminescence, as we have previously described. 10 In brief, vessels were opened longitudinally to expose the endothelial surface and equilibrated for 20 minutes in oxygenated (95% O 2 /5% CO 2 ) Krebs-HEPES buffer (pHϭ7.4) at 37°C. Lucigenin-enhanced chemiluminescence was measured with low-concentration lucigenin (5 mol/L). 10 Vascular superoxide generation from uncoupled nitric oxide synthase (NOS) was determined by the N G -nitro-L-arginine methyl ester (L-NAME, 100 mol/L)-inhibitable fraction of total superoxide release. The NADPH-induced superoxide generation (an indirect measure of NADPH oxidase activity) was determined after the addition of NADPH (100 mol/L). In our laboratory, the intra-assay variability for lucigenin-enhanced chemiluminescence is 3.2%, the interassay variability is 5.1%, and the lowest detection limit is 0.03 relative light units (RLU)/mg tissue).
Clinical End Points
The primary end point of the study was the development of AF during hospitalization, defined by methods we have previously described. 14, 15 During the immediate postoperative period, heart rhythm was monitored continuously for the first 48 hours and at 4-hour intervals thereafter for 5 days. Postoperative AF was defined as the characteristic arrhythmia lasting for at least 30 seconds. The secondary end point was AF at routine follow-up 6 weeks after surgery, classified as the presence of AF on an ECG. Additional clinical data were collected, including length of stay in the hospital, major cardiovascular events (myocardial infarction, need for redo surgery, unstable angina, or death) during the hospital stay or before 6 weeks, and New York Heart Association and Canadian Cardiovascular Society class preoperatively and at 6 weeks.
Statistical Analysis
All variables were tested for normal distribution by the Kolmogorov-Smirnov test. Variables not normally distributed were logarithmically transformed for analysis, and all variables are expressed as meanϮSEM or median (25th to 75th percentile), as appropriate. The impact of baseline variables on the development of postoperative AF was examined by estimating the odds ratios (ORs) and 95% CIs by logistic regression. A population of 120 patients was able to detect an OR of 1.89 per 1-SD change in log(sCD40L) with ␣ϭ0.05 and 80% power, assuming a 33% rate of AF after surgery. In multivariable logistic regression, the OR for 1 SD of log(sCD40L) was adjusted for age, sex, and those potential predictors (covariates) of AF (such as diabetes mellitus, hypertension, smoking, left atrial diameter, duration of operation, number of grafts used, systolic and diastolic blood pressures, preoperative creatinine value, New York Heart Association functional class, Canadian Cardiovascular Society score, Euroscore score, and Parsonnet score) that were associated with AF in bivariate analysis at the level of 15%, as appropriate. Reported correlations are Pearson's r coefficients. All reported probability values were compared with a significance level of 5%. SPSS version 15.0 (SPSS Inc, Chicago, Ill) was used for all analysis, except for power calculations, which were performed with NQuery Advisor version 7.0.
Results
Demographic and clinical characteristics of the study population are presented in the Table. One hundred forty-seven patients were screened for eligibility, and 144 patients were in sinus rhythm, were not taking amiodarone or digoxin preoperatively (98%), and were included in the analysis (Figure 1 ). During hospitalization, AF was detected in 43 of the 144 patients (32.6%).
There were no significant differences in the demographic characteristics between the patients who developed AF and those who remained in sinus rhythm. There was no difference in preoperative medications between groups, while drug doses were optimized in all patients preoperatively. In addition, all patients underwent surgery off-pump, and there were no significant differences in Parsonnet score, preoperative left ventricular function, or left atrial diameter between those patients who developed postoperative AF and those who remained in sinus rhythm (Table) . However, Euroscore was significantly higher in the AF group, with a trend for a longer total duration of operation (Table) .
Preoperative sCD40L and Markers of Systemic Inflammation
We first examined whether circulating preoperative levels of inflammatory markers (CRP and sICAM-1) or sCD40L predicted in-hospital development of AF. The 2 inflammatory markers, log(CRP) and sICAM-1, were weakly related to each other (rϭ0.34, Pϭ0.001) but not to log(sCD40L) (log[CRP], rϭ0.12, Pϭ0.3; sICAM-1, rϭϪ0.17, Pϭ0.2), a finding compatible with our previous observation that sCD40L is a marker of platelet activation rather than a systemic inflammatory marker in patients with advanced atherosclerosis. 16 Importantly, we found no significant association between preoperative CRP levels and the development of postoperative AF (median and 25th to 75th percentile range, 1.18 and 0.53 to 2.73 mg/mL in those who developed AF vs 1.15 and 0.63 to 3.18 mg/mL in those who remained in sinus rhythm, with OR and 95% CI per unit of log[CRP]ϭ1.00 and 0.65 to 1.53, respectively, Pϭ0.9). Similarly, preoperative levels of sICAM-1 were similar between those who developed postoperative AF (median and 25th to 75th percentile, 324 and 217 to 468 ng/mL) and those who remained in sinus rhythm (median and 25th to 75th percentile, 298 and 225 to 514 ng/mL, with ORϭ1.00, 95% CIϭ1.00 to 1.01 per unit of sICAM-1, Pϭ0.7). However, patients who developed postoperative AF had significantly higher preoperative levels of sCD40L ( Figure 2 ). The crude OR and 95% CI for a 1-SD change in log(sCD40L) were 1.89 and 1.21 to 2.97, respectively, Pϭ0.005. Patients in AF at 6 weeks (nϭ5) tended to have higher preoperative levels of sCD40L ( Figure 2 ) than those who remained in sinus rhythm, but again, preoperatively the inflammatory markers CRP and sICAM-1 were not different between those who developed AF (median and 25th to 75th percentile, 1.88 and 0.58 to 12.8 mg/mL and median and 25th to 75th percentile, 428 and 334 to 530 ng/mL, respectively) and those who remained in sinus rhythm (median and 25th to 75th percentile, 1.15 and 0.58 to 2.80 mg/mL and median and 25th to 75th percentile, 298 and 217 to 480 ng/mL, respectively). However, because of the small number of patients with AF at 6 weeks, formal statistical tests were not performed for any of these data.
Preoperative Vascular Endothelial Function
We then examined whether preoperative vascular endothelial function was related to sCD40L levels and predicted the development of postoperative AF. Preoperative FMD was inversely correlated with preoperative levels of log(sCD40L) (rϭϪ0.23, Pϭ0.04) and sICAM-1 (rϭϪ0.29, Pϭ0.008) but not with log(CRP) (rϭϪ0.12 Pϭ0.23). In logistic-regression analysis, the OR and 95% CI for in-hospital postoperative AF per unit of FMD were 0.97 and 0.91 to 1.04, respectively, Pϭ0.43 (Figure 3 ). In contrast, in the small group of patients who were still in AF 6 weeks after surgery, preoperative FMD tended to be lower than in patients who were in sinus rhythm at 6 weeks (Figure 3 ). Endothelium-independent dilatation was not related to any factor (data not shown).
Vascular Superoxide Generation by LIMA and SV Grafts
We also examined whether systemic vascular superoxide production (basal and the NADPH-stimulated or L-NAMEinhibitable fraction) in LIMA or SV grafts was associated with sCD40L levels and predicted the development of postoperative AF. Preoperative log(sCD40L) levels were significantly correlated with basal superoxide generation in both LIMA (rϭ0.42, Pϭ0.007) and SV (rϭ0.37, Pϭ0.02) grafts, but there was no significant association between vascular superoxide generation and either CRP or sICAM-1 (data not shown). Superoxide generation in SV and LIMA grafts showed no association with postoperative AF in hospital ( Figure 4) mg in LIMA grafts from patients in sinus rhythm vs median and 25th to 75th percentile, 1.53 and 0.81 to 4.86 RLU/s per mg in SV grafts and median and 25th to 75th percentile, 4.68 and 1.29 to 15.9 RLU/s per mg in LIMA grafts from patients still in AF at 6 weeks). L-NAME-inhibitable superoxide tended to be significantly greater in those patients who developed AF in hospital compared with those who remained in sinus rhythm ( Figure  4) . Similarly, the group of patients who were still in AF at 6 weeks tended to have greater L-NAME-inhibitable superoxide generation in LIMA grafts (median and 25th to 75th percentile, Ϫ5.06 and Ϫ9.96 to 6.36 RLU/s per mg) compared with those who remained in sinus rhythm (median and 25th to 75th percentile, Ϫ0.20 and Ϫ1.25 to 0.49 RLU/s per mg). There was no association between vascular NADPHstimulated superoxide in either SV or LIMA grafts and the development of postoperative AF in hospital (Figure 4 ) or at 6 weeks (median and 25th to 75th percentile, 75.1 and 43.1 to 142.9 RLU/s per mg in SV grafts and median and 25th to 75th percentile, 87.5 and 53.8 to 158.4 RLU/s per mg in LIMA grafts from patients in sinus rhythm vs median (25th to 75th percentile 57.37 and 38.3 to 199.3 RLU/s per mg in SV grafts and median and 25th to 75th percentile, 124.4 and 44.5 to 206.2 RLU/s per mg in LIMA grafts from patients in AF at 6 weeks).
Multivariable Logistic Regression
To understand the impact on the association between sCD40L and AF of other related clinical and biologic factors, we performed multivariable logistic regression. As reported in the Table, only Euroscore (Pϭ0.01) and total duration of operation (Pϭ0.08) were associated with AF in bivariate analysis below the threshold of Pϭ0.15 and were included in the multivariable model, along with age and sex. sCD40L was the only independent predictor of postoperative AF with the adjusted OR and 95%CI for each variable in the model being as follows: for a 1-SD change in log(sCD40L), 1.97 and 1.21 to 3.22, Pϭ0.007; for male sex, 0.40 and 0.10 to 1.64, Pϭ0.2; for age (per 1 year), 1.00 and 0.91 to 1.10, Pϭ1.0; for Euroscore (per 1 U), 1.23 and 0.81 to 1.86, Pϭ0.3; and for the duration of operation (per minute), 1.00 and 1.00 to 1.02, Pϭ0.8.
Discussion
We have demonstrated for the first time that elevated preoperative levels of sCD40L are associated with a higher risk of developing AF after off-pump CABG surgery. Interestingly, the association of sCD40L with in-hospital AF was independent of systemic endothelial function, markers of systemic inflammation such as CRP and sICAM1, vascular redox state, or clinical markers such as Euroscore. Taken together, these findings suggest that preoperative levels of sCD40L, a marker of platelet activation, may be an important determinant of short-term risk of AF after CABG surgery.
Platelet Activation and Postoperative AF
AF is a frequent complication of cardiac surgery that is observed within the first 5 postoperative days in 35% to 50% of patients undergoing cardiac operations. 2, 17 Postoperative AF can induce hemodynamic instability and is associated with an increased risk of stroke and prolonged hospitalization. Recent evidence suggests that systemic and cardiac oxidative stress, inflammation, and thrombotic mechanisms (leading to myocardial ischemia) associated with coronary artery surgery may play important roles in postoperative arrhythmogenesis. 14, 15, 18, 19 Platelet activation links these mechanisms. sCD40L is a proinflammatory and prothrombotic molecule, belonging to the tumor necrosis factor superfamily. 20 Despite its role as an inflammatory mediator, sCD40L is mainly derived from activated platelets and triggers clot formation. 20 Indeed, evidence suggests that sCD40L reflects overall platelet activation, in particular, in patients with coronary atherosclerosis. 16 Recent studies have introduced the concept that sCD40L may be implicated both in the pathophysiology of AF and in the development of thrombotic complications in patients with AF. 7, 21 Whether preexisting platelet activation increases the risk of develop- ment of AF after the stimulus of coronary artery surgery has not been studied, although there are reasons why this may be important. 7 Increased levels of sCD40L would be associated with an increased risk of microthrombi formation and related ischemia after surgery. sCD40L is also involved in the regulation of proinflammatory transcriptional pathways, inducing myocardial oxidative stress 6 and inflammatory signaling, 5 both of which have been involved in the development of AF. 3, 14, 15 Indeed, we observed that increased preoperative sCD40L levels are associated with increased risk of postoperative AF, an effect that was independent of other clinical confounders or medication.
Superoxide production by atrial NADPH oxidases is a key stimulus for the development of postoperative AF. 14, 15 Myocardial oxidative damage is associated with atrial electrophysiologic remodeling and increased AF inducibility in animal models of rapid atrial pacing, both of which can be prevented by treatment with antioxidant and antiinflammatory drugs. 7, 22 Clinical trials have demonstrated that interventions that prevent activation of NADPH oxidases, eg, angiotensin II receptor blockers 23 and statins, 24 may prevent AF in various groups, including patients undergoing cardiac surgery. 24 Myocardium-derived free radicals are directly implicated in the pathophysiology of both paroxysmal and chronic AF. 14 Systemic platelet activation could increase vulnerability of the human myocardium to AF owing to a stimulatory effect on inflammation and oxidative stress directly within the myocardium.
Whether the relation between AF and redox state extended from the myocardium to systemic vascular oxidative stress is unknown. Our study suggests this is not the case, as neither high arterial vascular superoxide generation per se nor systemic endothelial function was associated with in-hospital AF. This would be consistent with our previous finding of a disconnect between atrial superoxide production and plasma markers of protein or lipid oxidation. 15 Preoperative endothelial function and redox state, largely due to uncoupled endothelial NOS (a condition wherein a reduction in the bioavailability of L-arginine or of the NOS cofactor tetrahydrobiopterin leads the enzyme to produce superoxide rather than NO), appeared to be different in those still in AF 6 weeks after surgery. Although this is a biologically plausible relation, the group of patients in AF was small and the results need further replication.
The present study does not prove a causal association between sCD40L levels and postoperative AF. In our analysis, we took account of a range of established potential biologic and clinical mediators and demonstrated that sCD40L was the only independent predictor of postoperative AF. However, our study was powered to look at biologic markers, and the sample size may have limited our ability to fully account for clinical factors. To establish whether platelet activation is the key feature, it will be important for future studies to include other more specific measures of platelet activity. All antiplatelet medication had been stopped in our patients but, if relevant, it is possible modification of platelet active medication near the time of surgery may provide some insight into these mechanisms. We did not have information on left atrial appendage velocities, because this measurement requires transesophageal echocardiography, which was not routinely performed in these patients. Alternatively, sCD40L may predict AF because of a link with other related postoperative clinical factors, such as infection or hemodynamic problems. In the current study, duration of inotrope use postoperatively had a borderline association with AF (Pϭ0.053) but did not explain the association between AF and preoperative factors.
This study has for the first time implicated preoperative serum levels of sCD40L as an independent risk factor for postoperative AF in patients undergoing off-pump CABG surgery. Future work will be able to determine the precise relation between sCD40L levels, platelet activation, and induction of AF after coronary artery surgery.
